Dr. Clemens Scherzer is a physician-scientist and the founding director of the APDA Center for Advanced Parkinson’s Disease Research of Brigham & Women’s Hospital and Harvard Medical School. He is director of the Precision Neurology Program of Brigham & Women’s Hospital and Associate Professor of Neurology at Harvard Medical School.
Dr. Scherzer uses genomes big data, and deep cohorts to develop predictive and proactive health care for Parkinson’s and neurologic diseases. To predict how the human genome codes brain cells in health and disease, he is establishing a Brain Cell Encyclopedia of transcribed elements in human brains. His interdisciplinary lab includes computer scientists, biologists and clinicians, and its goal is to match drugs and tests to a patient based on disease biology.
Dr. Scherzer has received the Dr. Paul Beeson and the George C. Cotzias Memorial Awards. He was nominated to the Scientific Advisory Board of the American Parkinson Disease Foundation, the Parkinson Research Vision Setting Panel of the U.S. Department of Defense, the editorial boards of Neurogenetics and Biomarkers in Medicine, and he co- chaired the Technical Working Group of the Accelerating Medicine Partnership Parkinson’s Disease (AMP PD) program.